IND/IDE Decision Guidance and Worksheet

Overview

This guidance is intended to assist clinical investigators, sponsors, sponsor-investigators, and institutional review boards (IRBs) in determining whether research studies involving human subjects require an Investigational New Drug application (IND).

The worksheet is intended as an exercise to help U-M investigators determine whether an IND may be required before initiating a new clinical study. This document can be provided to the IRB in support of an e-Research application prior to initiating an investigator-initiated clinical trial.


Downloads

FDA Guidance - Determining whether human research studies need an IND.pdf

IND Decision Worksheet.pdf


Questions and Disclaimer

Resources on this page may not be an exhaustive list. If you know of other resources in this category, please let us know using the "Suggest a Resource" link at the bottom of the page.

Was this article helpful?

Can’t find what you’re looking for?

Subscribe to Breakthrough, MICHR’s monthly e-newsletter